OhioHealth Settles Antitrust Allegations with DOJ and Ohio Attorney General
OhioHealth, a prominent 16-hospital nonprofit health system, has reached a settlement agreement with the U.S. Department of Justice (DOJ) and the Ohio Attorney General to address antitrust allegations. The lawsuit, initially filed in February, accused OhioHealth of leveraging its market dominance to coerce payers into noncompetitive contracts, allegedly breaching both federal and state competition laws.
Details of the Allegations
The DOJ and the Ohio Attorney General claimed that OhioHealth utilized its influence to compel commercial health insurers to prioritize its facilities in their health plans. This practice purportedly hindered insurers from offering more competitive, budget-conscious health plans, such as narrow or tiered options that could benefit consumers through lower costs.
Provisions of the Settlement
According to a DOJ press release, the proposed settlement, filed in the U.S. District Court for the Southern District of Ohio, prohibits OhioHealth from enforcing contract terms with insurers that obstruct the creation of budget-friendly health plans. Additionally, the health system is barred from preventing insurers from guiding patients toward more cost-effective care providers, as stated by the Ohio Attorney General’s office.
The lawsuit highlighted OhioHealth’s position as the dominant hospital system in the Columbus region, facing competition from Ohio State University Wexner Medical Center and Mount Carmel Health System, part of Trinity Health. The legal complaint noted that OhioHealth’s reimbursement rates were significantly higher than those of its local competitors, despite offering similar quality services.
Impact on Market Competition
The government argued that OhioHealth’s contractual terms violated the Sherman Act and the Valentine Act by mandating that insurers include all of its providers in their networks, thus reducing competition. The proposed consent judgment aims to nullify existing contract provisions that stifle the development of innovative and cost-effective health plans, ensuring that OhioHealth cannot pursue similar terms in future contracts.
Under the settlement, OhioHealth is also restricted from penalizing insurers for promoting budget-conscious health plans. Moreover, OhioHealth is required to submit periodic compliance reports to the DOJ’s Antitrust Division over the next five years.
Statements from Key Stakeholders
Assistant Attorney General Omeed A. Assefi from the DOJ’s Antitrust Division emphasized the importance of competition in healthcare, stating, “This settlement will ensure lower healthcare costs for Ohioans, and ending these anti-competitive contractual terms will restore competition for patients in the Columbus area.”
OhioHealth, while agreeing to the settlement, denied any wrongdoing. The organization maintains that its contracting practices have been lawful and appropriate. OhioHealth will not incur penalties or fines as part of the settlement.
“The contractual provisions in question date back up to two decades and were intended to protect OhioHealth from insurance companies’ then-standard practices. Since then, both the healthcare and insurance landscapes have changed,” OhioHealth stated. The health system noted that no insurer had requested the removal of the disputed provisions.
As a nonprofit, faith-based health system, OhioHealth reiterated its commitment to providing high-quality, accessible, and affordable healthcare, opting to resolve the dispute to avoid costly and prolonged litigation.
Broader Implications and Precedents
This case mirrors similar antitrust claims against other large health systems, such as NewYork-Presbyterian, accused of imposing restrictive payer agreements. Previously, notable settlements include a $575 million agreement with Sutter Health in California and a $228.5 million class-action settlement against the same organization.
For further information, you can read more about the OhioHealth settlement Here.
“`
